One of the qualitative objectives of Chugai's fundamental goal of becoming a top pharmaceutical company is to be a “company that satisfies all its stakeholders and receives their active support and trust.”
We have received messages from experts in various fields. I am very grateful for their comments, which showed me first-hand the rising expectations and requests that people have for Chugai. At the same time, I recognize that further innovation and value creation will be necessary for us to fulfill our mission of contributing to the medical community and human health around the world.
The wide-ranging expectations for Chugai include creation of innovative new drugs, leadership in healthcare and the pharmaceutical industry, development of the next generation of young people and leaders, and co-existence with communities.
In a nutshell, we are expected to be a partner in resolving society’s problems.
As we strive for further innovation, it is important that we collaborate with all our stakeholders and deliver value to society.
Looking at the operating environment ahead, we will enter an age of extreme uncertainty marked by such trends as a declining birth rate and aging population, the growing need to contain healthcare costs, and the emergence of disruptive technologies. In such conditions, businesses should focus in particular on the qualitative aspects of management. Corporate growth is no longer defined by profit growth alone – it is also defined by its processes and quality.
At Chugai, we have developed and implemented management strategies based on the belief that our corporate value is a comprehensive product of our economic performance, social awareness and human development. We will place priority on fusing these three elements on a higher plane as we go forward.